I like America; I holiday there regularly. It's civilised, it's escapist, and I've found many a great investment opportunity there.
But in many ways America is a sick nation. And by sick, I mean in the sense that a lot of Americans simply don't look after their health. A study taken in late 2011 revealed 60% of American adults can be classified as obese or overweight. This is putting a serious strain on the healthcare system.
Tired of dealing with chronic diseases caused by the lazy habits of an ageing population, healthcare providers are trying something new.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Modern technology has been called to the aid of a hamburger guzzling, Coca-Cola swilling nation. True to its form, the US is dressing this up with some fancy new jargon. The new buzzwords are connected health' and gamification' and if Fergus Kee and Paul Landau have anything to do with it, these two novel ideas could do something to alleviate the USA's chronic health problems.
America needs a radical new approach to healthcare
Kee and Landau are, respectively executive chairman and chief executive of Fitbug (AIM:FITB) and they believe that the time is ripe for a new approach to healthcare. The need is urgent. 17.5% of the USA's GDP is spent on healthcare. Even with the significant investment the American healthcare system incorporates, 16% of Americans lacked healthcare for the year. Insurance was either unaffordable or unavailable.
Consider this: health insurance for a family of four in the USA costs $17,500 - for just one year's cover. Much of this is paid by employers to health insurers, but president Obama's package of healthcare reforms is designed to make it easier to switch from one healthcare provider to another. So providers need to sharpen up their act, and that means offering a better deal. One solution is to offer discounts to individuals who do their best to stay healthy.
The prospect of a few hundred dollars in rebates at the end of the year might be enough to get some couch potatoes onto the exercise machine. Health insurers would happily hand back some cash in return for fewer medical claims. There is evidence that this approach can work. Those who go to the gym are 20% less likely to make a medical insurance claim although this may of course be because those who are healthy in the first place are more likely to go the gym.
Staying fit with a 'Fitbug'
But still, there is not much doubt that exercise is good for you, but the problem has been how to monitor our exercise levels. In the past the act of swiping a card to gain entry to the gym has provided some information. But now more sophisticated methods of data gathering are available.
One AIM-listed company that operates in this area is Toumaz (AIM:TMZ) whose smart plaster' monitors vital signs such as pulse rate and blood pressure and sends wireless signals to remote health monitors. The brainchild of the brilliant Dr Chris Toumaz and financially backed by Imagination Technologies (IMG) this is an interesting business, although this scarcely seems to justify its £96m stock market value.
Fitbug, on the other hand, has a stock market value of under £3m and a major contract or two could make that look very mean. Its product is a small device, about half the size of a mobile phone, which detects every step you take. You can put it round your neck or in your pocket and it will count your steps, classifying them as regular steps' or, if you kick up your heels, 'aerobic steps'.
It will then relay these to a database and thereby to your computer. There you can see how many steps you have totted up, you can input other details of your exercise swimming for example and, to make the whole procedure meaningful, you also tell the computer what you have eaten and drunk.
You can see where this is leading.
Could a rebate from an insurer help Fitbug launch gamification'?
Are you taking enough steps to burn off the calories? The system is designed to demonstrate your progress, and give you some messages of encouragement. It can also lead to gamification'. Here a group might be challenged to walk from Land's End to John O'Groats. They won't actually do this walk, but the number of footsteps will be monitored and their imaginary progress can be monitored against an online map. This could then take the form of a race or a group challenge, providing extra incentive to burn the shoe leather.
Connected health' is certainly seen as a business opportunity, and money has poured into start-ups, especially in the USA. But while most business plans target the consumer, Fitbug wants to sign deals with the health insurers and providers, who can then involve their insured customers.
Will it take off? I am happy to have my footsteps monitored but having to download my other personal habits sounds a bit of a chore. Perhaps though, the prospect of a rebate from the health insurer will launch this nascent industry into the mainstream. I am keeping an eye on Fitbug. Last week it announced further progress in Europe and is holding discussions with some very large health providers in the USA. It would not need many big contracts to make that £3m stock market value look ungenerous.
This article is taken from Tom Bulford's free twice-weekly small-cap investment email The Penny Sleuth. Sign up to The Penny Sleuth here.
Information in Penny Sleuth is for general information only and is not intended to be relied upon by individual readers in making (or not making) specific investment decisions. Penny Sleuth is an unregulated product published by Fleet Street Publications Ltd.
Tom worked as a fund manager in the City of London and in Hong Kong for over 20 years. As a director with Schroder Investment Management International he was responsible for £2 billion of foreign clients' money, and launched what became Argentina's largest mutual fund.
Now working from his home in Oxfordshire, Tom Bulford helps private investors with his premium tipping newsletter, Red Hot Biotech Alert.
Follow Tom on Google+.
Who is the richest person in the world?
The top five richest people in the world have a combined net worth of $825 billion. Who takes the crown for the richest person in the world?
By Vaishali Varu Published
Top 10 stocks with highest growth over past decade - from Nvidia, Microsoft to Netflix, which companies made you the most money?
We reveal the 10 global companies with the biggest returns since 2013. One firm has posted an astonishing 9,870% return, meaning a £1,000 investment would now be worth almost £82,000.
By Ruth Emery Published
Somero: trading this overlooked bargain
Features Mechanical-screed maker Somero dominates its niche and is attractively valued. Matthew Partridge picks the best way to trade it.
By Dr Matthew Partridge Published
How to find big profits in small companies
Cover Story The small- and micro-cap sectors are risky and volatile. But with careful research and patience, investors could make huge gains. Matthew Partridge explains how to find the market’s top tiddlers.
By Dr Matthew Partridge Published
The hidden gems on Aim, London's junior market
Features Aim, London’s junior market, is risky – but you can find solid stocks at low prices. Scott Longley reports.
By Scott Longley Published
Is Aim finally coming of age?
Features The Aim market of mostly smaller companies has traditionally been seen as a bit of a backwater. Is it time to change that view? Matthew Partridge talks to Paul Latham and Richard Power of fund management company Octopus.
By Dr Matthew Partridge Published
Fetch! The Chinese small-cap stocks to buy in the Year of the Dog
Opinion Each week, a professional investor tells us where she’d put her money. This week: Tiffany Hsiao of Matthews Asia selects three Chinese small-cap stocks with exciting potential.
By Tiffany Hsio Published
Small and mid-cap stocks with big potential
Opinion Professional investor Guy Anderson of the Mercantile Investment Trust selects three small and medium-sized firms with promising prospects that the market has missed.
By Guy Anderson Published
Get cheap, reliable growth from smaller companies
Features One of the most reliable long-term investment trends is the long-term outperformance of smaller companies over blue chips. Max King picks some of the best ways to buy into this growth.
By Max King Published
Big gains from small caps
Features In an environment of middling inflation and low interest rates, small-cap stocks tend to beat big blue-chips. John Stepek explains why, and how to invest in them.
By John Stepek Published